The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of Endocrinology

• Publication date

  1989-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1677/JOE.0.1220331PMID 2769157
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progesterone receptors and human breast cancer

  2005cited by this paper
• Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells.

  1989cited by this paper
• Lipophilic impurities, not phenolsulfonphthalein, account for the estrogenic activity in commercial preparations of phenol red.

  1988cited by this paper
• Interaction of phenol red with estrogenic and antiestrogenic action on growth of human breast cancer cells ZR-75-1 and T-47-D.

  1988cited by this paper
• Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells.

  1988cited by this paper
• Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens.

  1987cited by this paper
• Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells.

  1987cited by this paper
• Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells.

  1987cited by this paper
• Basement membrane and the invasive activity of metastatic tumor cells.

  1986cited by this paper
• Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells.

  1986cited by this paper
• Use of two MCF-7 cell variants to evaluate the growth regulatory potential of estrogen-induced products.

  1986cited by this paper
• Triphenylethylenes: a new class of protein kinase C inhibitors.

  1986cited by this paper
• Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.

  1985cited by this paper
• Dose-dependent effect of 17 beta-estradiol determined by growth curves and flow cytometric DNA analysis of a human breast carcinoma (T61) grown in nude mice.

  1985cited by this paper
• Hormone-induced tumor flare.

  1985cited by this paper
• Antiestrogen action in breast cancer cells: Modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites

  1985cited by this paper
• Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture.

  1984cited by this paper
• Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells.

  1983cited by this paper
• Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro.

  1983cited by this paper
• Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones.

  1983cited by this paper
• An antiestrogen-binding protein in human tissues.

  1983cited by this paper
• Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review).

  1983cited by this paper
• Effect of estradiol on human breast cancer cells in culture.

  1983cited by this paper
• Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice.

  1983cited by this paper
• Unusual androgen sensitivity of the androgen-independent Dunning R-3327-G rat prostatic adenocarcinoma: androgen effect on tumor cell loss.

  1982cited by this paper
• Intraneoplastic diversity.

  1982cited by this paper
• Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice.

  1981cited by this paper
• Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens.

  1981cited by this paper
• Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice.

  1980cited by this paper
• Prolonged retention of estradiol by human breast cancer cells in tissue culture.

  1979cited by this paper
• Physiological and pharmacological effects of estrogens in breast cancer.

  1979cited by this paper
• Interactions of antiestrogens with human breast cancer in long-term tissue culture.

  1976cited by this paper
• Progression from hormone dependence to autonomy in mammary tumors as an in vivo manifestation of sequential clonal selection.

  1975cited by this paper
• Estrogen receptor content and hormone-responsive growth of mouse mammary tumors.

  1974cited by this paper

• Experimental models of endocrine responsive breast cancer: strengths, limitations, and use

  2021cites this paper
• Nuclear estrogen receptors co-activation mechanisms.

  2013cites this paper
• Co-Inhibition of BCL-W and BCL2 Restores Antiestrogen Sensitivity through BECN1 and Promotes an Autophagy-Associated Necrosis

  2010cites this paper
• IFNγ Restores Breast Cancer Sensitivity to Fulvestrant by Regulating STAT1, IFN Regulatory Factor 1, NF-κB, BCL2 Family Members, and Signaling to Caspase-Dependent Apoptosis

  2010cites this paper
• Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

  2009cites this paper
• Acquisition of Hormone-independent Growth in MCF-7 Cells Is Accompanied by Increased Expression of Estrogen-regulated Genes but Without Detectable DNA Amplifications

  2007influential citation
• Collateral resistance to oestrogen and erbB receptor activated growth in endocrine resistant breast cancer

  2007cites this paper
• Advances in Brief Stimulation by Bombesin and Inhibition by Bombesin / Gastrin-releasing Peptide Antagonist RC-3095 of Growth of Human Breast Cancer Cell Lines 1

  2006cites this paper
• Fibroblast Growth Factor 4 Transfection of MCF-7 Cells Produces Cell Lines That Are Tumorigenic and Metastatic in Ovariectomized or Tamoxifen-treated Athymic Nude Mice 1

  2006cites this paper
• Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-basedin vitro assays

  2005cites this paper
• Human breast cancer cell line xenografts as models of breast cancer — The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines

  2005cites this paper
• The nude mouse as anin vivo model for human breast cancer invasion and metastasis

  2005cites this paper
• Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression

  2004cites this paper
• The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells

  2004cites this paper
• In vitro antineoplastic activity of C7-substituted mitomycin C analogues MC-77 and MC-62 against human breast-cancer cell lines

  2004cites this paper
• Synergistic effect of estrogen and VEGF on the proliferation of hemangioma vascular endothelial cells.

  2004cites this paper
• In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells.

  2004cites this paper
• Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling

  2003cites this paper
• Development of cross-resistance to tamoxifen in raloxifene-treated breast carcinoma cells.

  2002cites this paper
• Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro.

  2002cites this paper
• Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.

  2001cites this paper
• Interaction of PAH-related compounds with the α and β isoforms of the estrogen receptor

  2001cites this paper
• Constitutive Expression of the Steroid Sulfatase Gene Supports the Growth of MCF-7 Human Breast Cancer Cells in Vitroand in Vivo.

  2001cites this paper
• Molecular and pharmacological aspects of antiestrogen resistance.

  2001cites this paper
• Interaction of PAH-related compounds with the alpha and beta isoforms of the estrogen receptor.

  2001cites this paper
• Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo.

  2001cites this paper
• A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.

  2001cites this paper
• Cellular and molecular pharmacology of antiestrogen action and resistance.

  2001influential citation
• Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells.

  2000cites this paper
• cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype

  1999influential citation
• Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells.

  1998cites this paper
• Molecular Analysis of Two Mammary Carcinoma Cell Lines at the Transcriptional Level as a Model System for Progression of Breast Cancer

  1998cites this paper
• Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells

  1998cites this paper
• Differential gene expression in mammary carcinoma cell lines: identification of DRIM, a new gene down-regulated in metastasis.

  1998cites this paper
• The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.

  1998cites this paper
• Short- and long-term oestradiol treatment inhibits growth and alters expression of p21WAF1/Cip1 in an endometrial adenocarcinoma cell line lacking functional p53.

  1997cites this paper
• MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.

  1997cites this paper
• Assignment of the human progression associated protein (PAP) to chromosome 12p12.3.

  1997cites this paper
• Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models

  1997cites this paper
• Differential gene expression in human mammary carcinoma cells: identification of a new member of a receptor family.

  1997cites this paper
• Expression of the invasive phenotype by MCF-7 human breast cancer cells transfected to overexpress protein kinase C-alpha or the erbB2 proto-oncogene.

  1997cites this paper
• Estradiol induces DNA fragmentation in a human endometrial adenocarcinoma with estradiol-inhibited growth phenotype.

  1997cites this paper
• Steroid hormones and cancer: (II) Lessons from experimental systems.

  1997cites this paper
• Steroid hormones and cancer: (II) lessons from experimental system

  1997cites this paper
• Acquisition of an antiestrogen-resistant phenotype in breast cancer: role of cellular and molecular mechanisms.

  1996cites this paper
• Mechanisms of Resistance to Antiestrogens and Their Implications for Crossresistance

  1996cites this paper
• Characterisation of a human endometrial adenocarcinoma established in vivo and in vitro.

  1996cites this paper
• MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer.

  1996cites this paper
• Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity.

  1996cites this paper
• The 12-lipoxygenase gene-transfected MCF-7 human breast cancer cell line exhibits estrogen-independent, but estrogen and omega-6 fatty acid-stimulated proliferation in vitro, and enhanced growth in athymic nude mice.

  1996cites this paper
• Growth inhibition in response to estrogen withdrawal and tamoxifen therapy of human breast cancer xenografts evaluated by in vivo 31P magnetic resonance spectroscopy, creatine kinase activity, and apoptotic index.

  1995cites this paper
• Effect of estrogen withdrawal on energy-rich phosphates and prediction of estrogen dependence monitored by in vivo 31P magnetic resonance spectroscopy of four human breast cancer xenografts.

  1995cites this paper
• Breast Cancer Cell Metabolism Studied by MRS.

  1995cites this paper
• Changes in steroid receptor activation, cell kinetics and tumor growth rate, during progression of human endometrial adenocarcinomas growing in nude mice: a brief review

  1995cites this paper
• Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen:31P NMR studies

  1995cites this paper
• potential of human breast cancer cells in vitro

  1994cites this paper
• 1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro.

  1994cites this paper
• 1α,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cellsin vitro

  1994cites this paper
• Inhibitory effect of bombesin/gastrin‐releasing peptide antagonist RC‐3095 and luteinizing hormone—releasing hormone antagonist SB‐75 on the growth of MCF‐7 MIII human breast cancer xenografts in athymic nude mice

  1994cites this paper
• Inhibitory effect of bombesin/gastrin-releasing peptide (GRP) antagonists RC-3950-II and RC-3095 on MCF-7 MIII human breast cancer xenografts in nude mice.

  1994cites this paper
• Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens?

  1993cites this paper
• Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.

  1993cites this paper
• Hormone resistance, invasiveness, and metastatic potential in breast cancer

  1993cites this paper
• Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.

  1993cites this paper
• Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays.

  1993cites this paper
• MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.

  1993cites this paper
• The nude mouse as an in vivo model for human breast cancer invasion and metastasis.

  1993cites this paper
• Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions.

  1992cites this paper
• Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines

  1992cites this paper
• Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells.

  1992cites this paper
• Regulation of tumor-host interactions in breast cancer.

  1992cites this paper
• Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH

  1992cites this paper
• Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines.

  1992cites this paper
• Molecular determinants of growth, angiogenesis, and metastases in breast cancer.

  1992cites this paper
• An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol.

  1992cites this paper
• The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs.

  1992cites this paper
• Characterization of an estradiol-independent but estradiol-responsive growth phenotype in a human endometrial adenocarcinoma heterotransplanted into nude mice

  1991cites this paper
• Effect of suramin on human prostate cancer cells in vitro.

  1991cites this paper
• Regulation of basement membrane invasiveness in human breast cancer model systems.

  1991cites this paper
• Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroids.

  1990cites this paper
• The process of malignant progression in human breast cancer.

  1990cites this paper
• Suramin, a novel antitumor compound.

  1990cites this paper
• 5. Human breast‐cancer growth and progression: Role of secreted polypeptide growth factors

  1990cites this paper
• Regulation of breast cancer cells by hormones and growth factors: effects on proliferation and basement membrane invasiveness.

  1989cites this paper
• Number DAMD 1796-1-6130 TITLE : Suppressor Genes in Breast Cancer

  year unknowncites this paper